Viromed Medical AG Capital Reinvestment Ratio

Latest as of December 2024: 4.82x

Viromed Medical AG capital reinvestment ratio. Viromed Medical AG (Q11) has a Capital Reinvestment Ratio of 4.82x as of December 2024, meaning it reinvests 5% of its operating cash flow (€7.45 Million) in capital expenditures (€35.91 Million). Check Viromed Medical AG total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

4.82x

Capex / Operating Cash Flow

Operating Cash Flow

€7.45 Million

EUR

Capital Expenditures

€35.91 Million

EUR

Data as of

Dec 2024

Most recent filing

Viromed Medical AG Capital Reinvestment Ratio by Year (None–None)

Viromed Medical AG capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see how efficiently does Viromed Medical AG generate cash.

Year	Reinvestment Ratio	Operating CF (EUR)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow